Blog | HemaCare

Plasmonic Nano Vectors Can Activate Dendritic Cells

Aug 25, 2017 12:23:31 PM / by Stacy Matthews Branch, DVM, PhD posted in cancer treatment, Dendritic cells, Nanotechnology, pnv

0 Comments

Conventional cancer treatment strategies are toxic to normal cells and lead to severe adverse effects for patients with cancer. To avoid exposure of chemotherapeutic agents to healthy tissue, controlled delivery of drugs targeting only tumor tissue would have significant clinical value. Research efforts in developing nanotechnology-based delivery systems can provide significant cancer treatment options; however, the choice of materials is crucial for their efficacy and safety.

Read More

Magnetic, Nanoscale Artificial APCs Could Be the Key to an Effective Cancer Immunotherapy

Sep 16, 2015 1:00:45 PM / by Karina Palomares posted in adoptive cell therapy, Cancer Immunology, cancer immunotherapy, Nanotechnology, T cells

0 Comments

Researchers have developed a streamlined technology for the enrichment and expansion of tumor-specific lymphocytes for adoptive immunotherapy.

Read More

Matchmaker for Stem Cells: Rejuvenation of Injured Heart by Antibody-Budded Nanoparticles

Nov 19, 2014 1:00:32 PM / by Shweta posted in Bone marrow, bone marrow-derived mononuclear stem cells, cell therapy, Hematopoietic History, Independent validation, Innovation, myocardial infarction, Nanotechnology, regenerative medicine, research, stem cells

0 Comments

A "nanomatchmaker" for an alliance between the injured heart and traveler stem cells

Stem cell transplantations are emerging as a potential therapeutic option in the field of regenerative medicine. In one of our previous blogs, we have mentioned possible roles of stem cells in cardiac regeneration. In spite of several clinical trials, the success of stem cell transplantation in heart regeneration is still not nailed down completely. Some studies signified promising clinical outcomes, while others reported no difference. The role of bone marrow-derived mononuclear stem cells (BMMNCs) has also been investigated in patients with heart failure, and unfortunately results are not uniformly positive. Delivery of these therapeutic cells is always a major hurdle to achieve complete clinical success. Therefore, novel approaches are required for efficient targeted delivery of these cells to the site of injury.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts